CRT 2023
Atherosclerosis and Vulnerable Plaque
Paul A. Gurbel, MD, FSCAI
DirectorSinai Center for Thrombosis Research and Drug DevelopmentBaltimore, Maryland, United States
Disclosure(s): Werfen: Grant/Research Support (Ongoing)